Related Experiment Videos
Thalassemias: simple screening for hereditary anemias
1Columbia University School of Nursing, New York.
Insights
Thalassemia minor, a carrier state for a fatal blood disease, can be identified through routine blood tests. Early diagnosis of thalassemia minor prevents unnecessary anemia treatment and guides reproductive health decisions.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Thalassemias are the most common inherited blood disorders globally.
- Thalassemia major is a severe, often fatal condition, while thalassemia minor represents the carrier state.
- 100,000 children worldwide are born with thalassemia major annually.
Purpose of the Study:
- To highlight the importance of identifying thalassemia minor in clinical practice.
- To emphasize the role of early diagnosis in preventing unnecessary medical interventions.
- To inform healthcare practitioners about preconception counseling and screening responsibilities.
Main Methods:
- Evaluation of routine red-blood-cell indices for potential identification.
- Confirmation of diagnosis through hemoglobin A2 (Hgb A2) evaluation.
Main Results:
- Thalassemia minor can be easily identified using standard red-blood-cell indices.
- Hgb A2 evaluation confirms the diagnosis of thalassemia minor.
- Knowledge of carrier status allows for avoidance of unnecessary anemia treatments.
Conclusions:
- Early identification and diagnosis of thalassemia minor are crucial for patient management.
- Healthcare providers must educate patients on carrier status, preconception counseling, and partner screening.
- Proactive screening and referral for potential congenital diseases are essential for reproductive-aged individuals.
Abstract:
The most prevalent hemoglobinopathies in the world, thalassemias are hereditary microcytic anemias. Each year, 100,000 children throughout the world are born with thalassemia major, a fatal blood disease. Thalassemia minor is the carrier state for this catastrophic disease. Health practitioners can easily identify patients who may have thalassemia minor through evaluation of routine red-blood-cell indices, and diagnosis can be confirmed by Hgb A2 evaluation. Once individuals know they have thalassemia minor, a lifetime of unnecessary treatment for anemia can be avoided. Patient education should also include information about preconception counseling and partner screening. Recognition of the potential for congenital diseases and subsequent screening or referral are the responsibilities of all health care practitioners who see clients before and during their reproductive years.